Aptorum Group Limited announced that its subsidiary company, Aptorum Innovations Holding Limited, has commenced clinical validation of its molecular based rapid pathogen diagnostics liquid biopsy technology for the diagnosis of pathogens including viruses, bacteria, fungi and parasites.
January 10, 2022
· 6 min read